Treatment of hepatitis C virus-associated thrombocytopenic purpura with a combination of interferon alfa-2b and ribavirin

J Clin Gastroenterol. 2002 Aug;35(2):200-1. doi: 10.1097/00004836-200208000-00015.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Drug Therapy, Combination
  • Female
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Purpura, Thrombocytopenic / drug therapy*
  • Purpura, Thrombocytopenic / etiology
  • Recombinant Proteins
  • Ribavirin / therapeutic use*
  • Treatment Outcome

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Ribavirin